Skip to main content
Top
Published in: Clinical and Experimental Nephrology 5/2010

01-10-2010 | Case Report

Apparent diffusion coefficient map based on diffusion-weighted magnetic resonance imaging is useful in diagnosing the brainstem variant of reversible posterior leukoencephalopathy syndrome with uremia

Authors: Kenichi Katano, Yasushi Kakuchi, Akikatsu Nakashima, Katsuyuki Nakahama, Mitsuhiro Kawano

Published in: Clinical and Experimental Nephrology | Issue 5/2010

Login to get access

Abstract

A 54-year-old Japanese man entered our hospital for investigation of appetite loss. His blood pressure was 201/113 mmHg, and laboratory findings revealed renal failure and hyponatremia. On physical examination, disorientation and dysarthria were observed. Hemodialysis was performed the same day. Magnetic resonance imaging (MRI) after hemodialysis revealed swelling of the brainstem and a high signal intensity on fluid-attenuated inversion recovery (FLAIR) imaging, similar to findings of central pontine myelinolysis (CPM), which is generally irreversible. However, on an apparent diffusion coefficient (ADC) map based on diffusion-weighted MRI, higher signal intensity was observed in the area of the high signal intensity on FLAIR imaging, which is not seen in CPM. The abnormal neurological symptoms improved within a few days, and MRI findings also normalized. We diagnosed the lesion as the brainstem variant of reversible posterior leukoencephalopathy syndrome (RPLS) with uremia. ADC map was very useful in diagnosing RPLS with uremia.
Literature
1.
go back to reference Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494–500.CrossRefPubMed Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494–500.CrossRefPubMed
2.
go back to reference Utsumi K, Amemiya S, Iizuka M, Iino Y, Katayama Y. Acute posterior leukoencephalopathy in a patient with nephrotic syndrome. Clin Exp Nephrol. 2003;7:63–6.CrossRefPubMed Utsumi K, Amemiya S, Iizuka M, Iino Y, Katayama Y. Acute posterior leukoencephalopathy in a patient with nephrotic syndrome. Clin Exp Nephrol. 2003;7:63–6.CrossRefPubMed
3.
go back to reference Chang GY, Keane JR. Hypertensive brainstem encephalopathy: three cases presenting with severe brainstem edema. Neurology. 1999;53:652–4.PubMed Chang GY, Keane JR. Hypertensive brainstem encephalopathy: three cases presenting with severe brainstem edema. Neurology. 1999;53:652–4.PubMed
4.
go back to reference Nagata M, Maeda M, Tsukahara H, Maier SE, Takeda K. Brain stem hypertensive encephalopathy evaluated by line scan diffusion-weighted imaging. AJNR Am J Neuroradiol. 2004;25:803–6.PubMed Nagata M, Maeda M, Tsukahara H, Maier SE, Takeda K. Brain stem hypertensive encephalopathy evaluated by line scan diffusion-weighted imaging. AJNR Am J Neuroradiol. 2004;25:803–6.PubMed
5.
go back to reference Cramer SC, Stegbauer KC, Schneider A, Mukai J, Maravilla KR. Decreased diffusion in central pontine myelinolysis. AJNR Am J Neuroradiol. 2001;22:1476–9.PubMed Cramer SC, Stegbauer KC, Schneider A, Mukai J, Maravilla KR. Decreased diffusion in central pontine myelinolysis. AJNR Am J Neuroradiol. 2001;22:1476–9.PubMed
6.
go back to reference Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008;29:1036–42.CrossRefPubMed Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008;29:1036–42.CrossRefPubMed
7.
go back to reference Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol. 2008;29:1043–9.CrossRefPubMed Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol. 2008;29:1043–9.CrossRefPubMed
8.
go back to reference Schwartz RB, Mulkern RV, Gudbjartsson H, Jolesz F. Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis. AJNR Am J Neuroradiol. 1998;19:859–62.PubMed Schwartz RB, Mulkern RV, Gudbjartsson H, Jolesz F. Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis. AJNR Am J Neuroradiol. 1998;19:859–62.PubMed
9.
go back to reference Kitaguchi H, Tomimoto H, Miki Y, Yamamoto A, Terada K, Satoi H, et al. A brainstem variant of reversible posterior leukoencephalopathy syndrome. Neuroradiology. 2005;47:652–6.CrossRefPubMed Kitaguchi H, Tomimoto H, Miki Y, Yamamoto A, Terada K, Satoi H, et al. A brainstem variant of reversible posterior leukoencephalopathy syndrome. Neuroradiology. 2005;47:652–6.CrossRefPubMed
10.
go back to reference Chen CL, Lai PH, Chou KJ, Lee PT, Chung HM, Fang HC. A preliminary report of brain edema in patients with uremia at first hemodialysis: evaluation by diffusion-weighted MR imaging. AJNR Am J Neuroradiol. 2007;28:68–71.PubMed Chen CL, Lai PH, Chou KJ, Lee PT, Chung HM, Fang HC. A preliminary report of brain edema in patients with uremia at first hemodialysis: evaluation by diffusion-weighted MR imaging. AJNR Am J Neuroradiol. 2007;28:68–71.PubMed
11.
go back to reference Yoon CH, Seok JI, Lee DK, An GS. Bilateral basal ganglia and unilateral cortical involvement in a diabetic uremic patient. Clin Neurol Neurosurg. 2009;111:477–9.CrossRefPubMed Yoon CH, Seok JI, Lee DK, An GS. Bilateral basal ganglia and unilateral cortical involvement in a diabetic uremic patient. Clin Neurol Neurosurg. 2009;111:477–9.CrossRefPubMed
12.
go back to reference Soupart A, Penninckx R, Stenuit A, Decaux G. Azotemia (48 h) decreases the risk of brain damage in rats after correction of chronic hyponatremia. Brain Res. 2000;852:167–72.CrossRefPubMed Soupart A, Penninckx R, Stenuit A, Decaux G. Azotemia (48 h) decreases the risk of brain damage in rats after correction of chronic hyponatremia. Brain Res. 2000;852:167–72.CrossRefPubMed
Metadata
Title
Apparent diffusion coefficient map based on diffusion-weighted magnetic resonance imaging is useful in diagnosing the brainstem variant of reversible posterior leukoencephalopathy syndrome with uremia
Authors
Kenichi Katano
Yasushi Kakuchi
Akikatsu Nakashima
Katsuyuki Nakahama
Mitsuhiro Kawano
Publication date
01-10-2010
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 5/2010
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-010-0293-0

Other articles of this Issue 5/2010

Clinical and Experimental Nephrology 5/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine